DCI 50th

John Strickler, MD, and team's milestone work on the clinical trial "MOUNTAINEER" has led to the first FDA-approved treatment regimen for HER2+ metastatic colorectal cancer.

The hybrid retreat showcased the latest gastric cancer, blood cancer, pediatric sarcoma, glioblastoma, breast cancer, and immune micro-environment research.

The Duke Med Alumni News Fall '22 Issue's cover story is "Researchers at Duke are Creating More Precise Approaches to Stopping Tumors."

As Duke celebrates more than 50 years of cancer breakthroughs, a new research program works toward a future when no one ever develops cancer.

Learn how the Precision Cancer Medicine Initiative is advancing research, extending lives, and breaking down barriers to access.

The Duke BioRepository & Precision Pathology Center, a Duke School of Medicine Service Center and DCI Shared Resource turns 10.

Learn about new developments in next generation molecular sequencing tests at the DUHS Clinical Labs' Clinical Molecular Diagnostics Laboratory.

Learn about some notable BRPC/DCI cancer research collaborations and why the partnership is core to winning big grants for cancer research.

DCI oncologists — doctors Davidson, Kamal, Moss, Secord, Menendez, and Kelley — blaze a trail, at the national level, in breast & gynecologic cancers.

The 2022 Shingleton Society dinner honored four awardees for their service in advancing the fight against cancer and paid video tribute to Cancer Center founder William Shingleton, MD.

The Radiation Research Society bestowed its highest honor — the Failla Memorial Lecture Award — on Michael B. Kastan, MD, PhD, executive director of DCI.

The Division of Gynecologic Oncology, Duke Department of OB-GYN commemorates 50 years of innovation and care.

"Just ASK," a course developed and piloted at DCI by Nadine Barrett, PhD, to help improve equity, diversity, and inclusion in cancer clinical trials, has gone national.

A research team led by Ann Marie Pendergast, PhD, found, in animal studies, that a leukemia drug disrupted HER2-positive breast cancer-spread to the brain.

A multi-disciplinary team fortifies a spine metastasis patient with expertise, care, and support, for her best life possible.

The Division of Nuclear Medicine and Radiotheranostics was named a Comprehensive Radiopharmaceutical Therapy Center of Excellence; one of only 14 in the U.S.

Duke University Hospital in Durham ranks #22 on the list of Best Hospitals for Cancer in the nation and has the highest ranked cancer program in the Southeastern U.S.

Looking to the Next Half Century

As Duke celebrates its 50th anniversary of cancer discovery and care, researchers and providers envision the future.

Meet the mom and daughter who lit the virtual Tree of Hope at the Duke Cancer Patient Support Programʼs 31st annual Tree of Hope Lighting Ceremony.

The Preston Robert Tisch Brain Tumor Center kicked off Brain Tumor Awareness Month (May) on April 30 with their first full-scale Angels Among Us event since the pandemic began.

Clinical providers, researchers, staff & health leaders came together to celebrate the 50th anniversary of the Duke Comprehensive Cancer Center (now DCI).

Gloria Bass, MA, has been a part of the Duke Health family for 41 years, including 26 years at DCI.

As Duke celebrates its 50th anniversary of transforming cancer discovery and care, researchers and providers look toward the next half century. 

In a lot of ways, Susan Blackwell (Crawford), MHS, PA-C’89, and the physician assistant profession have grown up together.